Gold Shield Group TV Commercial, 'Type-2 Diabetes Medication Side Effects'
0
0
Gold Shield Group announces that various medications such as Invokana, Invokamet, Jardiance and Farxiga are linked to an increased risk of toe, leg and foot amputations. Type-2 Diabetics who suffered serious side effects after taking these medications are encouraged to call and file a claim.
Zeig mehr
0 Bemerkungen
sort Sortiere nach
Facebook Kommentare